Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Nov;97(11):1333-1334.
doi: 10.1002/jnr.24518. Epub 2019 Aug 21.

In Focus: Disease promoters during epileptogenesis

Thimmasettappa Thippeswamy  1
Affiliations

In Focus: Disease promoters during epileptogenesis

Thimmasettappa Thippeswamy. J Neurosci Res. 2019 Nov.
No abstract available

PubMed Disclaimer

References

    1. https://www.cdc.gov/media/releases/2017/p0810-epilepsy-prevalence.html.
    1. Bialer M, Johannessen SI, Levy RH, Perucca E, Tomson T, White HS. Progress report on new antiepileptic drugs: A summary of the Thirteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIII). Epilepsia. 2017. February;58(2):181–221. doi: 10.1111/epi.13634. Epub 2017 Jan 23. Review. PubMed PMID: . - DOI - PubMed
    1. Temkin NR. Antiepileptogenesis and seizure prevention trials with antiepileptic drugs: meta-analysis of controlled trials. Epilepsia. 2001. 42(4):515–24. PMID: . - PubMed
    1. Kwan P, Brodie MJ Epilepsy after the first drug fails: substitution or add-on? Seizure. 2000. 9 (7): 464–468. DOI: 10.1053/seiz.2000.0442. PMID: . - DOI - PubMed
    1. Kwan P, et al. Drug-resistant epilepsy. N Engl J Med. 2011. 365 (10):919–26. doi: 10.1056/NEJMra1004418. PMID: . - DOI - PubMed

Publication types